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ABSTRACT 
Objective: The present study was formulated in order to determine the novelty and the potency of the synthesized phosphate esters in terms of 
their antibacterial activity.  
Methods: Mono-6-chloro-2,4-dinitroaniline phosphate and di-2-methyl-5-nitroaniline phosphate were screened for antibacterial activity against 
four pathogenic bacterial strains Staphylococcus aureus MTCC 3160, Klebsiella oxytoca ATCC 13182, Bacillus subtilis BAB 2437 and Bacillus 
licheniformis MS 17. Antibacterial activity was evaluated by the broth dilution assay method at different concentrations (50-2000µg/ml) of 
phosphate esters. Solutions of mono-and di phosphate esters were prepared in water and DMSO respectively. Growth of inoculums was noted in 
terms of optical density.  
Results: Di-2-methyl-5-nitroaniline phosphate was found more active than mono-6-chloro-2,4-dinitroaniline phosphate against selected bacterial 
strains. The minimum inhibitory concentration (MIC) of both phosphate esters was found in the range of 25 to 50 µg/ml. Minimum bactericidal 
concentration (MBC) of mono-6-chloro-2,4-dinitroaniline phosphate was found in the range of 1000 to 1500µg/ml against Staphylococcus aureus, 
Klebsiella oxytoca, Bacillus subtilis and Bacillus licheniformis. Di-2-methyl-5-nitroaniline phosphate showed MBC of 500 and 400 µg/ml against 
Staphylococcus aureus and Klebsiella oxytoca respectively, and 1000 µg/ml against Bacillus subtilis and Bacillus licheniformis.  
Conclusion: Both the phosphate esters have exhibited significant antibacterial activity, therefore these compounds may be a good antibacterial agent. 
Keywords: MIC, MBC, Antibacterial activity, Broth dilution assay.  
 
INTRODUCTION 
Antibiotics are undeniably one of the most important therapeutic 
discovery of the 20th century that had effectiveness against serious 
bacterial infections. These drugs cause a dramatic change not only in 
the treatment of infectious disease, but of a fate of mankind. Now 
day’s resistance to antibacterial agents by human pathogenic 
bacteria is an increasingly serious worldwide health issue. The most 
pressing concerns are particularly with regard to the problematic 
human bacterial pathogens as well as fungal pathogens. They 
constitute a considerable portion of biomass in the earth [1-3]. Most 
of microorganisms can cause infectious diseases and therefore, the 
control of microbial growth is necessary in many practical 
situations. Because of available antibiotic failure to treat infectious 
diseases, many researchers have focused their work on synthesis of 
new bioactive compounds [4-6].  
Staphylococcus aureus is a versatile human pathogen associated with 
a broad range of serious community-acquired and nosocomial 
diseases in humans, from minor skin and skeletal infections to 
severe infections such as septicemia, pneumonia [7-8]. It is a leading 
cause of food poisoning, resulting from the consumption of food 
contaminated with enterotoxins. Staphylococcal food intoxication 
involves the rapid onset of nausea, vomiting, abdominal pain, 
cramps, and diarrhoea [9-10]. Infections with this microorganism 
are especially difficult to treat because the strains are often resistant 
to one or more antibiotics, including methicillin. The increasing 
prevalence of methicillin-resistant Staphylococcus aureus (MRSA), 
and its ability to spread in the hospitals and the community, has 
posed a major challenge for infection control [11]. Klebsiella oxytoca 
is another important opportunistic pathogen that can cause various 
nosocomial and community infections, including septicemia, 
pneumonia, urinary tract infection, and antibiotic associated 
hemorrhagic colitis [12-13]. It is purported to be an etiological agent 
of antibiotic-associated hemorrhagic colitis (AAHC) in adults and 
adolescents [14-16]. Although most strains of Bacillus subtilis and 
Bacillus licheniformis are non-pathogenic, some variants of Bacillus 
subtilis are known to cause diseases in severely immuno 
compromised patients, and can conversely be used as a probiotic in 
healthy individuals. It rarely causes food poisoning [17-18]. Bacillus 
licheniformis are the predominant pathogenic Bacillus species and 
have been responsible for cases of bacteremia, septicemia, and 
peritonitis, food-poisoning syndrome, ophthalmitis, ventriculitis, 
and cerebral abscess [19-22]. It is very essential to control the 
growth of pathogenic strains of bacteria, by avoiding their microbial 
growth by means of new bacteriostatic agents.  
Phosphate esters are normally considered as pharmacological 
compounds and have attracted considerable interest on account of 
their diverse potential biological activity [23-24]. Some formulations 
of these esters are used as drugs for curing various diseases in 
medicine and veterinary science [25-28]. Most of non polymeric 
phosphate esters that occur in the cell might be considered as lead 
compounds for the development of drugs [29].  
These esters are also used as a pro drug to enhance the water 
solubility of the parent drug [30]. Several studies have shown that 
phosphate esters have remarkable chemotherapeutic activities such 
as antitumor, anti-cancerous, antibacterial, antifungal, and antiviral 
activities [31-33]. There are very few reports on the study of bio-
activity of phosphate esters. Therefore, in the present study attempt 
was made to synthesize phosphate esters with C-N-P linkage and 
evaluate their bioactivity in terms of antibacterial activity against 
different pathogenic bacterial strains such as Staphylococcus aureus 
MTCC 3160, Klebsiella oxytoca ATCC 13182, Bacillus subtilis BAB 
2437 and Bacillus licheniformis MS 17.  
MATERIALS AND METHODS 
Synthesis of mono-6-chloro-2,4-dinitroaniline phosphate was done 
by the method described by Cavalier which involves the reaction of 
6-chloro-2,4-dinitroaniline and phosphorus pentaoxide in 1:1 mol 
ratio. Di-2-methyl-5-nitroaniline phosphate was synthesized by the 
method described by Rudert, which involves the reaction of parent 
compound 2-methyl-5-nitroaniline and phosphorus oxychloride in 
2:1 mol ratio [34]. All the chemicals used in these experiments were 
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of analytical grade. The chemical structures of mono and di-
























II. Di-2-methyl-5-nitroaniline phosphate 
 
To test the antibacterial activity of phosphate esters bacterial strains 
were procured from the collections of School of Studies in 
Biotechnology, Pt. Ravishankar Shukla University, Raipur, 
Chhattisgarh, India, as Staphylococcus aureus MTCC 3160, Klebsiella 
oxytoca ATCC 13182, Bacillus subtilis BAB 2437 and Bacillus 
licheniformis MS 17.  
Evaluation of antibacterial activity of phosphate esters was carried 
out by determining the MIC of phosphate esters for all selected 
bacterial strains using two different methods. The classical method 
involves diffusion assays in which test compound is poured on the 
wells of an agar plate that has been inoculated with test bacteria. 
During the incubation the test compound diffuses, creating a 
concentration gradient that produces a zone of bacterial growth 
inhibition [35]. In the early 1970s, automated systems were 
developed for assay of bacterial antibiotic susceptibility. These 
systems were an automated version of the classical method in which 
the test compound is added to the suspensions of bacterial culture to 
measure the bacterial growth [36]. 
In general the pure cultures of all selected bacterial strains were 
grown in Nutrient agar medium (NAM) at 37 °C. Grown bacterial 
cultures on nutrient agar slants were aseptically taken and 
inoculated into 50 ml of sterile broth. Then these were shacked 
thoroughly and incubated at 37 oC for 24 h. These cultures were 
designated as the working stock and used for antibacterial studies of 
phosphate esters. 
Nutrient broth medium inoculated in different test tubes plugged 
with sterile cotton and autoclaved. Stock solutions of mono and di 
phosphates were prepared in water and dimethyl sulphoxide 
(DMSO) respectively. A set of different concentrations (25-2000 
μg/ml) was designed by diluting the stock solution of test 
compounds in test tubes containing nutrient broth medium to test 
the antibacterial activity of phosphate esters employing broth 
dilution assay method [37]. In this method, each tube was inoculated 
with 100 μl of bacterial suspensions and incubated at 37 oC for 24±1 
and 48±1 h. Growth of inoculums in the test tube was observed by 
determining the optical density (OD) at 600 nm by colorimeter. 
Measurements of control were carried out without the addition of 
test compounds. Percentage of growth inhibition of bacterial strains 
was calculated with respect to growth of control by the formula as 
given below.  
 
The inhibitory activity of the phosphate esters was also evaluated by 
well diffusion method [38, 39]. The diameter of the mean inhibition 
zones at different concentrations of phosphate esters was measured. 
Gentamycin standard antibiotic (500µg/ml) was used as a positive 
control and distilled water as a negative control to check the 
bioactivity of synthesized phosphates. After testing the antibacterial 
activity by this method, experiments were performed to determine 
the MIC of phosphate esters in nutrient broth medium by broth 
dilution assay method. Minimum inhibitory concentration (MIC) is 
defined as the lowest concentration of material able to inhibit the 
growth of an organism [40].  
Minimum inhibitory concentration is important in diagnostic 
laboratories to confirm resistance of microorganisms to antimicrobial 
agent and also to monitor the activity of new antimicrobial agents. In 
this study MIC50, MIC90 and MIC99 were determined which corresponds 
to the concentrations that inhibit 50, 90 and 99% of bacterial growth 
respectively. The lowest concentration with no visible growth was 
defined as the minimum bactericidal concentration (MBC), indicating 
99.9% killing of the microorganisms [40]. All experiments were 
repeated three times. 
RESULTS  
Bacterial culture of selected bacterial strains showed typical 
kinetics of bacterial growth in nutrient broth media at different 
concentration of phosphate esters. It can be seen from the 
results that there was the decrease in absorbance with increase 
in concentration of phosphate esters. The bactericidal effect of 
the phosphate esters was dependent on the concentration of 
phosphate esters and initial bacterial concentration. The results 
of bacterial growth kinetics at different concentrations of 
phosphate esters against selected bacterial strains are shown in 
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Fig. 1: Microbial growth kinetics of selected bacterial strains of 
Mono-6-chloro-2,4-dinitroaniline phosphate 
 
The antibacterial activity of phosphate esters was evaluated in terms 
of percentage of growth inhibition. Both the phosphate esters showed 
significant activity against all selected bacterial strains. The minimum 
inhibitory concentration of both phosphate esters was found in the 
range of 25 to 50 µg/ml. At 25µg/ml, mono-6-chloro-2,4-dinitroaniline 
phosphate showed the percentage of growth inhibition as 14.33±0.59, 
19.69±1.11 9.14±0.48 after 24 h and 28.30±0.69, 30.47±0.42, 
16.90±1.34 after 48 h against Staphylococcus aureus, Klebsiella oxytoca, 
Bacillus subtilis respectively. But in the case of Bacillus licheniformis no 
growth inhibition was found after 24 h. The percentage growth 
inhibition found was 15.95±1.16 only after 48 h. Di-2-methyl-5-
nitroaniline phosphate showed the higher percentage of growth 






Fig. 2: Microbial growth kinetics of selected bacterial strains of 
Di-2-methyl-5-nitroaniline phosphate 
 
The percentage of growth inhibition found against 
Staphylococcus aureus, Klebsiella oxytoca, and Bacillus subtilis 
was 23.73±1.55, 37.01±0.58, 18.76±1.40 after 24 h and 
44.27±2.12, 48.38±0.96, 28.40±0.87 after 48 h respectively. In 
case of Bacillus licheniformis di-phosphate showed similar 
observation as monophosphate. Percentage of growth inhibition 
found was 20.45±2.27 only after 48 h. Percentage of growth 
inhibition of mono-6-chloro-2,4-dinitroaniline phosphate and di-
2-methyl-5-nitroaniline phosphate are summarized in table 1,2 
and table 3,4 respectively. 
MIC50, MIC90, MIC99 and MBCs value for mono-6-chloro-2,4-
dinitroaniline phosphate and di-2-methyl-5-nitroaniline phosphate 
against different selected bacterial strains were calculated and 
shown in table 5. Di-2-methyl-5-nitroaniline phosphate exhibited 
higher activity for all selected bacterial strains as compared to 
mono-6-chloro-2,4-dinitroaniline phosphate.  
All selected bacterial strains depicted significant sensitivity for 
phosphate esters. Mono-6-chloro-2,4-dinitroaniline phosphate 
showed MBC at the concentration of 1000 µg/ml for Staphylococcus 
aureus, Klebsiella oxytoca and Bacillus licheniformis while at the 
concentration of 1500 µg/ml for Bacillus subtilis. Di-2-methyl-5-
nitroaniline phosphate showed MBC at the concentration of 400 
µg/ml for Klebsiella oxytoca and at the concentration of 500 µg/ml 
against Staphylococcus aureus. The MBC against, Bacillus subtilis and 
Bacillus licheniformis found were at the concentration of 1000 and 
1500 µg/ml respectively. 
 
Table 1: Percentage of growth inhibition of Mono-6-chloro-2,4-dinitroaniline phosphate after 24 h 









25 14.33±0.59 19.69±1.11 9.14±0.48 ---- 
50 28.67±1.19 50.98±0.98 18.28±0.96 13.22±1.06 
100 47.61±1.21 64.62±0.21 39.34±1.56 30.16±1.59 
200 66.73±1.43 76.68±1.04 60.66±1.57 51.85±4.15 
300 78.50±0.88 86.32±0.98 75.91±2.14 60.32±3.18 
400 85.66±0.59 94.01±0.62 85.05±2.51 73.54±2.12 
500 93.61±0.85 96.67±3.81 90.86±0.48 86.77±1.06 
1000 100 100 96.67±3.33 100 
1500 ------- ------- 100 ---- 
2000 ------ ------ ------ ---- 
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Table 2: Percentage of growth inhibition of Mono-6-chloro-2,4-dinitroaniline phosphate after 48 h 









25 28.30±0.69 30.47±0.42 16.90±1.34 15.95±1.16 
50 52.70±2.37 53.71±1.11 34.08±1.42 28.87±1.02 
100 66.00±2.18 67.14±1.09 57.40±0.75 44.17±4.06 
200 77.01±0.53 82.82±1.70 70.26±0.79 57.56±3.37 
300 86.24±2.22 89.00±0.35 83.11±1.34 76.07±1.74 
400 91.83±0.49 95.18±1.04 87.57±3.03 84.05±1.15 
500 95.92±0.25 97.56±1.22 95.95±2.02 92.02±0.58 
1000 100 100 100 100 
1500 ------- ------- ---- ---- 
2000 ----- ----- ----- ---- 
 
Table 3: Percentage of growth inhibition of Di-2-methyl-5-nitroaniline phosphate after 24 h 









25 23.73±1.55 37.01±0.58 18.76±1.40 ---- 
50 38.06±1.25 62.74±0.42 35.13±0.92 14.48±1.20 
100 52.39±1.21 72.93±0.75 48.48±1.52 29.13±2.27 
200 73.89±1.61 84.71±0.50 64.87±0.92 52.38±2.38 
300 85.66±0.59 94.90±0.16 75.43±1.70 71.03±2.41 
400 92.83±0.29 100 83.62±1.13 81.35±3.25 
500 100 ---- 91.81±0.57 85.51±1.21 
1000 ---- ---- 100 95.24±2.38 
1500 ---- ---- ---- 100 
2000 ---- ---- ---- ---- 
 
Table 4: Percentage of growth inhibition of Di-2-methyl-5-nitroaniline phosphate after 48 h 









25 44.27±2.12 48.38±0.96 28.40±0.87 20.45±2.27 
50 62.32±1.20 70.91±0.91 42.75±2.18 41.16±2.64 
100 72.62±2.82 78.26±1.18 56.99±1.83 58.84±2.63 
200 85.79±1.14 89.19±1.28 75.69±2.74 76.52±2.73 
300 92.20±0.20 96.77±0.10 81.57±0.78 85.35±2.81 
400 96.20±0.10 100 87.71±0.52 85.35±2.81 
500 100 ---- 93.86±0.26 94.19±2.91 
1000 ---- ---- 100 100 
1500 ---- ---- ---- ---- 
2000 ---- ---- ---- ---- 
 
Table 5: MIC and MBC of phosphate esters by broth dilution assay method 








Mono-6-chloro-2,4-dinitroaniline phosphate Staphylococcus aureus MTCC 3160 100 500 1000 1000 
Klebsiella oxytoca  
ATCC 13182 
50 400 1000 1000 
Bacillus subtilis 
BAB 2437 
200 500 1500 1500 
Bacillus licheniformis 
MS 17 
200 1000 1500 1500 
Di-2-methyl-5-nitroaniline phosphate Staphylococcus aureus MTCC 3160 100 400 500 500 
Klebsiella oxytoca  
ATCC 13182 
50 300 400 400 
Bacillus subtilis 
BAB 2437 
100 500 1000 1000 
Bacillus licheniformis 
MS 17 
200 1000 1000 1000 
 
The inhibitory activity of phosphate esters at different concentration 
was also tested by the well diffusion method. Zones of inhibition are 
summarized in table 6. 500µg/ml of Gentamycin was screened to 
check the bioactivity of phosphate esters against selected bacterial 
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strains. Inhibition zones found were 21.33±0.29, 29.78±0.36, 
19.26±0.26, 22.45±0.24 against Staphylococcus aureus, Klebsiella 
oxytoca, Bacillus subtilis and Bacillus licheniformis respectively. At 
the same concentration of monoester inhibition zones found were 
11.45±0.18, 12.33±0.28, 10.78±0.32, 10.56±0.24 against 
Staphylococcus aureus, Klebsiella oxytoca, Bacillus subtilis and 
Bacillus licheniformis respectively. Inhibition zones of di-phosphate 
esters found were 18.11±0.26, 19.11±0.35, 14.22±0.36, 12.67±0.33 
against Staphylococcus aureus, Klebsiella oxytoca, Bacillus subtilis and 
Bacillus licheniformis respectively. 
 
Table 6: Inhibitory activities of phosphate esters by well diffusion method 
Phosphate esters Bacterial strains Concentration µg/ml Zone of inhibition in mm 
Mono-6-chloro-2,4-dinitroaniline phosphate Staphylococcus aureus MTCC 3160 100 ---- 
400 9.44±0.18 
1000 12.78±0.28 















Di-2-methyl-5-nitroaniline phosphate Staphylococcus aureus MTCC 3160 100 11.00±0.24 
500 18.11±0.26 
1000 20.33±0.24 















“----”shows no inhibition zone  
 
DISCUSSION 
The growth of infectious diseases and increase in bacterial 
resistance to traditional antibiotics has created the necessity for 
studies of antimicrobial activity. Therefore, many researchers have 
focused their studies on the synthesis of bioactive compounds and 
their antibacterial activity. Very limited work has been reported 
regarding the bioactivity of the phosphate esters till now.  
In present investigation mono-6-chloro-2,4-dinitroaniline 
phosphate and di-2-methyl-5-nitroaniline phosphate were 
synthesized by the method described earlier [34] and screened to 
test their bioactivity against pathogenic bacterial strains by well 
diffusion and broth dilution assay methods. Standard antibiotic 
Gentamycin was taken as a positive control to check their 
bioactivity. This preliminary test was done by the well diffusion 
method. Standard antibiotic and phosphate esters showed better 
accessibility through well and easily diffused across the medium by 
forming a clear zone of inhibition. After testing the bioactivity by 
well diffusion method, MIC and MBC were determined by applying 
broth dilution assay method in nutrient broth medium. Different 
values of MIC were observed by well diffusion and broth dilution 
assay methods for both mono and di phosphates.  
Both the phosphates were found more sensitive against gram 
negative bacterial strain Klebsiella oxytoca than gram positive 
bacterial strains such as Staphylococcus aureus, Bacillus subtilis and 
Bacillus licheniformis. This could be attributed to the structural 
differences of the cell wall of gram positive and gram negative 
bacteria. Broth dilution assay method seems to be better than well 
diffusion method, because in the well diffusion method, there may 
be chances of an increase in the relative error in the measurement of 
inhibition zones with a precision of 1 mm diameter. The high 
sensitivity of the broth dilution assay compared to well diffusion 
tests may be attributed to better interaction of phosphate esters 
with bacterial cells. MIC values were lower than the MBC values, 
suggesting that the phosphate esters were bacteriostatic at lower 
concentration but bactericidal at higher concentration. Similar study 
was reported earlier by Bhoite et. al.[5, 36, 41]. They have reported 
the synthesis of mono and di-ethylaniline phosphate and their 
antibacterial activity by the paper disc diffusion and broth dilution 
assay methods against four gram negative bacteria. The results of 
present compounds were found more significant than the reported 
earlier. Similarly Kumar et al. [42] have reported antibacterial 
activity of ethyl N-aryl-2,6-dioxo-piperid-3-ene-4-corboxylates by 
paper disc diffusion method against Gram-negative bacterial species 
Escherichia coli, Salmonella typhimurium and Gram-positive 
bacterial species Bacillus substilis, Staphylococus aureus. They have 
also reported minimum inhibitory concentrations (MICs) by broth 
dilution technique. Naga Raju et. al.[43] have reported the 
antibacterial activity of 6-Substituted [(1,2, 6,2)] oxathiaza-
phosphonin-6-ones by Kirby-Bauer’s disc diffusion method against 
Staphylococcus aureus and Escherichia coli.  
CONCLUSION 
Mono-6-chloro-2,4-dinitroaniline phosphate and di-2-methyl-5-
nitroaniline phosphate have exhibited significant antibacterial 
activity against selected bacterial strains. Di-2-methyl-5-nitroaniline 
phosphate has shown more activity than mono-6-chloro-2,4-
dinitroaniline phosphate. Therefore, these compounds may be useful 
in pharmaceutical chemistry as a good antibacterial agent. 
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